Physician profile
Brad C White
NPI 1205810512
$8,657.37
in general payments reported to CMS, 2019-2025
51 companies · $3,017 in 2025
The $3,017 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $624 · 2020: $237 · 2021: $905 · 2022: $1,024 · 2023: $1,679 · 2024: $1,171 · 2025: $3,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,773 · Travel and Lodging: $2,094.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,773.37 |
| Travel and Lodging | $2,094.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $2,094.38 | 2025 | |
| Boston Scientific Corporation | $505.25 | 2019-2025 | Lumenis Pulse 120h |
| Urogen Pharma, INC. | $448.89 | 2023-2025 | Jelmyto |
| Pfizer INC. | $438.10 | 2019-2025 | |
| Intuitive Surgical, INC. | $431.65 | 2019-2024 | Da Vinci Surgical System |
| Astellas Pharma US INC | $412.46 | 2019-2023 | Myrbetriq |
| Dendreon Pharmaceuticals LLC | $410.30 | 2021-2024 | Provenge |
| Accord Healthcare, INC. | $371.64 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $323.77 | 2021-2025 | Keytruda, Welireg, Lynparza |
| Myriad Genetic Laboratories, INC. | $277.87 | 2021-2023 | Prolaris |
| Allergan, INC. | $258.31 | 2019-2022 | |
| Abbvie INC. | $250.47 | 2022-2025 | Botox |
| Bayer Healthcare Pharmaceuticals INC. | $218.59 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $207.69 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $134.44 | 2023-2025 | Orgovyx, Gemtesa |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.